1. General Information | 2. Conditions | 3. Catalogue Items | 4. Attestation Documents | 5. Contract Document | 6. Budget Setting

General Information   Back To Top Summary Summary Contract Unique Identifier DO1.SLCNTR.484181   Contract reference MISPAS-2020-00931   Contract description: Adquisición de Medicamentos de Alto Costo por el mecanismo de Excepción   Type of Contract Goods   Contract Start: 30/11/2020 00:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)   Contract End: 31/12/2020 00:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)   Legally Binding? YesOnly Award Notice   Contract State Completed   Contracting Company Identification Contracting Company Identification Supplier Company Identification Supplier Company Identification Object Info Object Info E-Procurement Profile: DGCP-08-ProcesosExcepcion   Request Reference MISPAS-CCC-PEEX-2020-0002   Request Title Adquisición de Medicamentos de Alto Costo por el mecanismo de Excepción   Description Adquisición de Medicamentos de Alto Costo por el mecanismo de Excepción, a través de la modalidad proveedor exclusivo, para ser utilizados en el periodo octubre 2020-mayo 2021, requeridos por el Programa de Alto Costo y Ayudas Médicas Directas, según oficios Dir-Alto-Costo-1133-1150-2020 d/f 28/09/2020 y 02/10/2020, susc. Alfre Dionicio Cruz Hernández, Director   Business Operation Programa de medicamentos de Alto Costos y Ayudas Medicas Directas   Reply Reference Adquisición de Medicamentos de Alto Costo por el m   Type of Contract GoodsDominicana   Contract Value 244,148,794.8 Dominican Pesos   Conditions   Back To Top Financial & Delivery Conditions Financial & Delivery Conditions Delivery options DAP - Entregado en un punto (lugar de destino convenido)   Contract Start Date 30/11/2020 00:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)   Contract End Date 31/12/2020 00:00:00 ((UTC-04:00) Georgetown, La Paz, Manaus, San Juan)   Main site or location of works, place of delivery or performance   Payment Conditions Payment Conditions Payment Method   Invoice Payment Deadline 30 days   Contract Comments Contract Comments Comment: Catalogue Items   Back To Top     1   DO1.PCCNTR.1019922 ContractData Container   1.1     -         Total sin descuentos Valor del descuento Total ITBIS Total Otros Impuestos Subtotal Total 244,148,794.80 0.00 0.00 0.00 490,294,672.00 244,148,794.80         Referencia Código UNSPSC Cuenta presupuestaria Descripción Cantidad Unidad Precio unitario estimado Precio unitario Importe moneda orig. s/ITBIS % Desc. Descuento moneda original Monto Gravado (Obras) % ITBIS ITBIS Moneda Original % Otros Impuestos Otros impuestos moneda original Precio total estimado Valor del precio de respuesta         2 51111713 - Alemtuzumab 2.3.4.1.01 Atezolizumab 120mg/20ml 34 UD 389,900 390,000 13,260,000.00 0.00 0.00 0.00 26,513,200.00 13,260,000.00         3 51182304 - Acetato de oct(...)51182304 - Acetato de octreotida 2.3.4.1.01 Bevacizumab 100mg/4ml 200 UD 24,296 23,300 4,660,000.00 0.00 0.00 0.00 9,718,400.00 4,660,000.00         4 51182304 - Acetato de oct(...)51182304 - Acetato de octreotida 2.3.4.1.01 Bevacizumab 400mg/16ml 200 UD 97,069 105,340 21,068,000.00 0.00 0.00 0.00 38,827,600.00 21,068,000.00         6 51161708 - Dornasa alfa 2.3.4.1.01 Dornasa Alfa 2.5mg/2.5ml 525 UD 2,268 2,350 1,233,750.00 0.00 0.00 0.00 2,381,400.00 1,233,750.00         7 51161708 - Dornasa alfa 2.3.4.1.01 Erlotinib 150mg 1,560 UD 3,554 2,033.33 3,171,994.80 0.00 0.00 0.00 11,088,480.00 3,171,994.80         11 51201809 - Interferon 2.3.4.1.01 Interferon Beta 1 a 44mcg/0.5ml 2,160 UD 13,487.5 15,135 32,691,600.00 0.00 0.00 0.00 29,133,000.00 32,691,600.00         12 51201901 - Acetato de gla(...)51201901 - Acetato de glatiramer 2.3.4.1.01 Ocrelizumab 300mg/10ml 121 UD 446,000 441,000 53,361,000.00 0.00 0.00 0.00 108,378,000.00 53,361,000.00         13 51111902 - Docetaxel 2.3.4.1.01 Pertuzumab 420mg/14ml 75 UD 197,000 197,000 14,775,000.00 0.00 0.00 0.00 29,550,000.00 14,775,000.00         15 51101804 - Ciclopiroxolam(...)51101804 - Ciclopiroxolamina 2.3.4.1.01 Rituximab 100mg/10ml 225 UD 13,500 9,850 2,216,250.00 0.00 0.00 0.00 6,075,000.00 2,216,250.00         16 51101804 - Ciclopiroxolam(...)51101804 - Ciclopiroxolamina 2.3.4.1.01 Rituximab 500mg/50ml 900 UD 67,200 49,200 44,280,000.00 0.00 0.00 0.00 120,960,000.00 44,280,000.00         19 51111717 - Trastuzumab 2.3.4.1.01 Trastuzumab 600mg/5ml 150 UD 74,715 73,000 10,950,000.00 0.00 0.00 0.00 22,414,500.00 10,950,000.00         20 51201809 - Interferon 2.3.4.1.01 Valganciclovir 450mg 2,940 UD 1,384 980 2,881,200.00 0.00 0.00 0.00 8,220,960.00 2,881,200.00         21 51201606 - Influenza hemo(...)51201606 - Influenza hemofílica 2.3.4.1.01 Emicizumab 30mg 360 UD 106,991.85 110,000 39,600,000.00 0.00 0.00 0.00 77,034,132.00 39,600,000.00 Attestation Documents   Back To Top Contract Documents   Back To Top Contract Document Template Contract Document Template Description File Name CUOTA MALLEN GUERRA.pdf CUOTA MALLEN GUERRA.pdf Download ACTA DE ADJUDICACION MISPAS-CCC-PEEX-2020-0002.pdf ACTA DE ADJUDICACION MISPAS-CCC-PEEX-2020-0002.pdf Download Contrato Mallen Guerra PEEX-2020-0002.PDF Contrato Mallen Guerra PEEX-2020-0002.PDF Download Budget Setting   Back To Top Budget Settings Budget Settings Expenditure Objective Investment Source of Funds General Source Manual Integration? SNIP? YesNo SNIP Code Budget Total Value 4,213,884.87 DOP Budget Appropriation Value  DOP Account Value Annual Availability 2.3.4.1.01 4,213,884.87  DOP ---- View Payment Calendar ID Description Value Month Year 0   MEDICAMENTOS DE ALTO COSTO 2,156,683.93  DOP Diciembre 2020 0   MEDICAMENTOS DE ALTO COSTO 2,057,200.94  DOP Enero 2021 Certificate of Appropriation Year Certificate Code Certificate Version Certificate Value Certificate State Certificate Link 2020 2020.0207.01.0001.9804 1 2,156,683.93  DOP Vencido CUOTA NOVARTIS.pdf